Please assess the completion status of the following clinical trial:

Trial Title: Occlusion Versus Pharmacologic Therapy for Moderate Amblyopia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients must be 7 years old or younger with amblyopia due to strabismus or anisometropia~* Visual acuity in the amblyopic eye must be between 20/40 and 20/100~* Visual acuity in the sound eye or 20/40 or better~* At least 3 lines of acuity difference between the two eyes~Exclusion Criteria:~* More than two months of amblyopia therapy in the past two years~* Myopia (more than -0.50 D)

- Gender: ALL
- Minimum Age: None
- Maximum Age: 6 Years
- Healthy Volunteers: f

Study Arms:
- Patching (Type: ACTIVE_COMPARATOR): None
- Atropine (Type: ACTIVE_COMPARATOR): Atropine

Based on this trial design, predict the completion outcome and termination type (if applicable).